| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59.7M | $5.41B | +31.1% | 3.426% | 0.72% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 49.0M | $4.45B | +2.2% | 2.814% | 0.20% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 39.2M | $3.54B | +0.2% | 2.252% | 0.19% |
| 7 | Capital Research Global Investors | 36.9M | $3.35B | -25.9% | 2.119% | 0.47% |
| 8 | Capital International Investors | 34.7M | $3.15B | -7.6% | 1.990% | 0.65% |
| 9 | MORGAN STANLEY | 26.6M | $2.41B | -11.6% | 1.528% | 0.13% |
| 10 | NORGES BANK | 23.4M | $2.12B | — | 1.341% | 0.21% |
| 11 | FRANKLIN RESOURCES INC | 18.8M | $1.71B | -6.1% | 1.080% | 0.37% |
| 12 | GOLDMAN SACHS GROUP INC | 18.6M | $1.69B | +22.9% | 1.068% | 0.15% |
| 13 | NORTHERN TRUST CORP | 18.3M | $1.66B | -5.8% | 1.049% | 0.19% |
| 14 | BANK OF AMERICA CORP /DE/ | 17.7M | $1.60B | -8.3% | 1.015% | 0.10% |
| 15 | DEUTSCHE BANK AG\ | 16.7M | $1.52B | +18.6% | 0.959% | 0.44% |
| 16 | JPMORGAN CHASE & CO | 15.1M | $1.40B | -43.6% | 0.867% | 0.08% |
| 17 | WELLS FARGO & COMPANY/MN | 15.2M | $1.38B | -4.6% | 0.872% | 0.22% |
| 18 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13.6M | $1.23B | 0.0% | 0.780% | 0.84% |
| 19 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 13.4M | $1.22B | -13.8% | 0.767% | 0.39% |
| 20 | FMR LLC | 13.4M | $1.22B | +23.8% | 0.771% | 0.05% |
| 21 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 12.8M | $1.16B | -2.8% | 0.737% | 0.21% |
| 22 | CITADEL ADVISORS LLC | 12.1M | $1.09B | +215.9% | 0.693% | 0.06% |
| 23 | Legal & General Group Plc | 11.9M | $1.08B | -2.9% | 0.685% | 0.23% |
| 24 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 10.9M | $988.8M | +97.3% | 0.626% | 0.44% |
| 25 | AMERIPRISE FINANCIAL INC | 10.7M | $975.4M | -24.2% | 0.615% | 0.20% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ABT — a direct measure of their conviction.
| 77.77% |
| +1.80 pp |
| $172.43B |
| +19% |
| Q4 2024 | 2,943 | +4.8% | 75.97% | +2.30 pp | $144.44B | +0.7% |
| Q3 2024 | 2,808 | — | 73.67% | — | $143.43B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
ABT institutional ownership rose by 0.61 percentage points quarter-over-quarter, with a net change of -98 holders.
The top 10 institutions account for 45.6% of all reported 13F value in ABT, and the top 25 account for 61.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Abbott Laboratories (ABT) Institutional Ownership